TY - STD TI - Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Jr., Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Jr., Tomaselli GF and American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-S73. ID - ref1 ER - TY - STD TI - Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation and Guidelines ESCCfP. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European heart journal. 2012;33:1635-701. ID - ref2 ER - TY - JOUR AU - Robinson, J. G. AU - Stone, N. J. PY - 2015 DA - 2015// TI - The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk: a new paradigm supported by more evidence JO - European heart journal. VL - 36 UR - https://doi.org/10.1093/eurheartj/ehv182 DO - 10.1093/eurheartj/ehv182 ID - Robinson2015 ER - TY - STD TI - Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Jr., Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Jr., Tomaselli GF and American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-45. ID - ref4 ER - TY - STD TI - Dorresteijn JAN, Kaasenbrood L, Cook NR, van Kruijsdijk RCM, van der Graaf Y, Visseren FLJ, Ridker PM. How to translate clinical trial results into gain in healthy life expectancy for individual patients. Bmj-Brit Med J. 2016;352. ID - ref5 ER - TY - JOUR AU - Lloyd-Jones, D. M. AU - Leip, E. P. AU - Larson, M. G. AU - D'Agostino, R. B. AU - Beiser, A. AU - Wilson, P. W. AU - Wolf, P. A. AU - Levy, D. PY - 2006 DA - 2006// TI - Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age JO - Circulation. VL - 113 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.548206 DO - 10.1161/CIRCULATIONAHA.105.548206 ID - Lloyd-Jones2006 ER - TY - STD TI - Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D'Agostino RB, Massaro JM, van der Graaf Y, Cramer MJM, Kappelle LJ, de Borst GJ, Steg PG, Visseren FLJ. Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH Model. Journal of the American Heart Association. 2018. ID - ref7 ER - TY - BOOK AU - Leening, M. J. PY - 2016 DA - 2016// TI - Berry JD and Allen NB PB - Lifetime perspectives on primary prevention of atherosclerotic cardiovascular disease CY - Jama ID - Leening2016 ER - TY - JOUR AU - Wolbers, M. AU - Koller, M. T. AU - Witteman, J. C. AU - Steyerberg, E. W. PY - 2009 DA - 2009// TI - Prognostic models with competing risks: methods and application to coronary risk prediction JO - Epidemiology. VL - 20 UR - https://doi.org/10.1097/EDE.0b013e3181a39056 DO - 10.1097/EDE.0b013e3181a39056 ID - Wolbers2009 ER - TY - JOUR AU - Rutter, C. M. AU - Zaslavsky, A. M. AU - Feuer, E. J. PY - 2011 DA - 2011// TI - Dynamic microsimulation models for health outcomes: a review JO - Med Decis Making. VL - 31 UR - https://doi.org/10.1177/0272989X10369005 DO - 10.1177/0272989X10369005 ID - Rutter2011 ER - TY - STD TI - Cholesterol Treatment Trialists C, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J and Collins R. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670-81. ID - ref11 ER - TY - JOUR AU - Sabatine, M. S. AU - Giugliano, R. P. AU - Keech, A. C. PY - 2017 DA - 2017// TI - Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR, Committee FS and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease JO - The New England journal of medicine. VL - 376 UR - https://doi.org/10.1056/NEJMoa1615664 DO - 10.1056/NEJMoa1615664 ID - Sabatine2017 ER - TY - JOUR AU - Soran, H. AU - Schofield, J. D. AU - Durrington, P. N. PY - 2015 DA - 2015// TI - Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment JO - European heart journal. VL - 36 ID - Soran2015 ER - TY - JOUR AU - Zhang, X. L. AU - Zhu, Q. Q. AU - Zhu, L. AU - Chen, J. Z. AU - Chen, Q. H. AU - Li, G. N. AU - Xie, J. AU - Kang, L. N. AU - Xu, B. PY - 2015 DA - 2015// TI - Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials JO - BMC Med. VL - 13 UR - https://doi.org/10.1186/s12916-015-0358-8 DO - 10.1186/s12916-015-0358-8 ID - Zhang2015 ER - TY - JOUR AU - Simons, P. C. AU - Algra, A. AU - Laak, M. F. AU - Grobbee, D. E. AU - Graaf, Y. PY - 1999 DA - 1999// TI - Second manifestations of ARTerial disease (SMART) study: rationale and design JO - European journal of epidemiology. VL - 15 UR - https://doi.org/10.1023/A:1007621514757 DO - 10.1023/A:1007621514757 ID - Simons1999 ER - TY - JOUR AU - Bui, A. L. AU - Horwich, T. B. AU - Fonarow, G. C. PY - 2011 DA - 2011// TI - Epidemiology and risk profile of heart failure JO - Nat Rev Cardiol. VL - 8 UR - https://doi.org/10.1038/nrcardio.2010.165 DO - 10.1038/nrcardio.2010.165 ID - Bui2011 ER - TY - JOUR AU - Heeringa, J. AU - Kuip, D. A. AU - Hofman, A. AU - Kors, J. A. AU - Herpen, G. AU - Stricker, B. H. AU - Stijnen, T. AU - Lip, G. Y. AU - Witteman, J. C. PY - 2006 DA - 2006// TI - Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study JO - European heart journal. VL - 27 UR - https://doi.org/10.1093/eurheartj/ehi825 DO - 10.1093/eurheartj/ehi825 ID - Heeringa2006 ER - TY - JOUR AU - Geskus, R. B. PY - 2011 DA - 2011// TI - Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring JO - Biometrics. VL - 67 UR - https://doi.org/10.1111/j.1541-0420.2010.01420.x DO - 10.1111/j.1541-0420.2010.01420.x ID - Geskus2011 ER - TY - JOUR AU - LaRosa, J. C. AU - Grundy, S. M. AU - Waters, D. D. PY - 2005 DA - 2005// TI - Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK and Treating to New Targets I. Intensive lipid lowering with atorvastatin in patients with stable coronary disease JO - The New England journal of medicine. VL - 352 UR - https://doi.org/10.1056/NEJMoa050461 DO - 10.1056/NEJMoa050461 ID - LaRosa2005 ER - TY - JOUR AU - Dorresteijn, J. A. AU - Visseren, F. L. AU - Wassink, A. M. AU - Gondrie, M. J. AU - Steyerberg, E. W. AU - Ridker, P. M. AU - Cook, N. R. AU - Graaf, Y. PY - 2013 DA - 2013// TI - Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score JO - Heart. VL - 99 UR - https://doi.org/10.1136/heartjnl-2013-303640 DO - 10.1136/heartjnl-2013-303640 ID - Dorresteijn2013 ER - TY - STD TI - Koopman CV, I. van Dis, I. Visser, MC. Bots, ML. Beroerte, met uitsplitsing naar subarachnoïdale bloeding, intracerebrale bloeding en herseninfarct. In: Koopman C, van Dis I, Vaartjes I, Visseren FLJ, Bots ML Hart- en vaatziekten in Nederland 2014, cijfers over kwaliteit van leven, ziekte en sterfte Den Haag: Hartstichting, 2014. ID - ref21 ER - TY - STD TI - Koopman CB, ML.; van Oeffelen, AAM.; van Dis, I.; Verschuren, WMM.; Engelfriet, PM.; Capewell, S.; Vaartjes, I. Trends in incidentie van acuut hartinfarct in de Nederlandse bevolking, 1998-2007. Hart- en vaatziekten in Nederland 2012, cijfers over risicofactoren, ziekte en sterfte Den Haag: Hartstichting, 2012. 2012. ID - ref22 ER - TY - STD TI - Dutch nationwide registries. http://statline.cbs.nl. Accessed on: 22-09-2016. UR - http://statline.cbs.nl ID - ref23 ER - TY - JOUR AU - Dennis, M. S. AU - Burn, J. P. AU - Sandercock, P. A. AU - Bamford, J. M. AU - Wade, D. T. AU - Warlow, C. P. PY - 1993 DA - 1993// TI - Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project JO - Stroke; a journal of cerebral circulation. VL - 24 UR - https://doi.org/10.1161/01.STR.24.6.796 DO - 10.1161/01.STR.24.6.796 ID - Dennis1993 ER - TY - JOUR AU - Criqui, M. H. AU - Denenberg, J. O. AU - Langer, R. D. AU - Fronek, A. PY - 1997 DA - 1997// TI - The epidemiology of peripheral arterial disease: importance of identifying the population at risk JO - Vasc Med. VL - 2 UR - https://doi.org/10.1177/1358863X9700200310 DO - 10.1177/1358863X9700200310 ID - Criqui1997 ER - TY - JOUR AU - Eldrup, N. AU - Budtz-Lilly, J. AU - Laustsen, J. AU - Bibby, B. M. AU - Paaske, W. P. PY - 2012 DA - 2012// TI - Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms JO - Journal of vascular surgery. VL - 55 UR - https://doi.org/10.1016/j.jvs.2011.08.046 DO - 10.1016/j.jvs.2011.08.046 ID - Eldrup2012 ER - TY - JOUR AU - Mosterd, A. AU - Cost, B. AU - Hoes, A. W. AU - Bruijne, M. C. AU - Deckers, J. W. AU - Hofman, A. AU - Grobbee, D. E. PY - 2001 DA - 2001// TI - The prognosis of heart failure in the general population: the Rotterdam study JO - European heart journal. VL - 22 UR - https://doi.org/10.1053/euhj.2000.2533 DO - 10.1053/euhj.2000.2533 ID - Mosterd2001 ER - TY - JOUR AU - Bronnum-Hansen, H. AU - Jorgensen, T. AU - Davidsen, M. AU - Madsen, M. AU - Osler, M. AU - Gerdes, L. U. AU - Schroll, M. PY - 2001 DA - 2001// TI - Survival and cause of death after myocardial infarction: the Danish MONICA study JO - J Clin Epidemiol. VL - 54 UR - https://doi.org/10.1016/S0895-4356(01)00405-X DO - 10.1016/S0895-4356(01)00405-X ID - Bronnum-Hansen2001 ER - TY - JOUR AU - Lampe, F. C. AU - Whincup, P. H. AU - Wannamethee, S. G. AU - Shaper, A. G. AU - Walker, M. AU - Ebrahim, S. PY - 2000 DA - 2000// TI - The natural history of prevalent ischaemic heart disease in middle-aged men JO - European heart journal. VL - 21 UR - https://doi.org/10.1053/euhj.1999.1866 DO - 10.1053/euhj.1999.1866 ID - Lampe2000 ER - TY - JOUR AU - Komocsi, A. AU - Simon, M. AU - Merkely, B. AU - Szuk, T. AU - Kiss, R. G. AU - Aradi, D. AU - Ruzsa, Z. AU - Andrassy, P. AU - Nagy, L. AU - Lupkovics, G. AU - Koszegi, Z. AU - Ofner, P. AU - Janosi, A. PY - 2016 DA - 2016// TI - Underuse of coronary intervention and its impact on mortality in the elderly with myocardial infarction. A propensity-matched analysis from the Hungarian Myocardial Infarction Registry JO - International journal of cardiology. VL - 214 UR - https://doi.org/10.1016/j.ijcard.2016.04.012 DO - 10.1016/j.ijcard.2016.04.012 ID - Komocsi2016 ER - TY - JOUR AU - Deasy, C. AU - Bray, J. AU - Smith, K. AU - Harriss, L. AU - Bernard, S. AU - Cameron, P. AU - Committee, V. S. PY - 2013 DA - 2013// TI - Functional outcomes and quality of life of young adults who survive out-of-hospital cardiac arrest JO - Emerg Med J. VL - 30 UR - https://doi.org/10.1136/emermed-2012-201267 DO - 10.1136/emermed-2012-201267 ID - Deasy2013 ER - TY - STD TI - Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S, Farje MR, Moncada G, Dutta A, Sazawal S, Dyer A, Seiler J, Aboyans V, Baker L, Baxter A, Benjamin EJ, Bhalla K, Bin Abdulhak A, Blyth F, Bourne R, Braithwaite T, Brooks P, Brugha TS, Bryan-Hancock C, Buchbinder R, Burney P, Calabria B, Chen H, Chugh SS, Cooley R, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, Davis A, Degenhardt L, Diaz-Torne C, Dorsey ER, Driscoll T, Edmond K, Elbaz A, Ezzati M, Feigin V, Ferri CP, Flaxman AD, Flood L, Fransen M, Fuse K, Gabbe BJ, Gillum RF, Haagsma J, Harrison JE, Havmoeller R, Hay RJ, Hel-Baqui A, Hoek HW, Hoffman H, Hogeland E, Hoy D, Jarvis D, Karthikeyan G, Knowlton LM, Lathlean T, Leasher JL, Lim SS, Lipshultz SE, Lopez AD, Lozano R, Lyons R, Malekzadeh R, Marcenes W, March L, Margolis DJ, McGill N, McGrath J, Mensah GA, Meyer AC, Michaud C, Moran A, Mori R, Murdoch ME, Naldi L, Newton CR, Norman R, Omer SB, Osborne R, Pearce N, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Pourmalek F, Prince M, Rehm JT, Remuzzi G, Richardson K, Room R, Saha S, Sampson U, Sanchez-Riera L, Segui-Gomez M, Shahraz S, Shibuya K, Singh D, Sliwa K, Smith E, Soerjomataram I, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Taylor HR, Tleyjeh IM, van der Werf MJ, Watson WL, Weatherall DJ, Weintraub R, Weisskopf MG, Whiteford H, Wilkinson JD, Woolf AD, Zheng ZJ, Murray CJ and Jonas JB. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129-2143. ID - ref32 ER - TY - JOUR AU - Sullivan, P. W. AU - Lawrence, W. F. AU - Ghushchyan, V. PY - 2005 DA - 2005// TI - A national catalog of preference-based scores for chronic conditions in the United States JO - Med Care. VL - 43 UR - https://doi.org/10.1097/01.mlr.0000172050.67085.4f DO - 10.1097/01.mlr.0000172050.67085.4f ID - Sullivan2005 ER - TY - STD TI - Dutch Health Care Insurance Board. Drug costs 2016. www.medicijnkosten.nl. Accessed on: 22-09-2016. UR - http://www.medicijnkosten.nl ID - ref34 ER - TY - STD TI - Dutch nationwide registries. www.kostenvanziekten.nl. Accessed on: 22-09-2016. UR - http://www.kostenvanziekten.nl ID - ref35 ER - TY - JOUR AU - Greving, J. P. AU - Visseren, F. L. AU - Wit, G. A. AU - Algra, A. PY - 2011 DA - 2011// TI - Statin treatment for primary prevention of vascular disease: whom to treat? JO - Cost-effectiveness analysis. BMJ. VL - 342 ID - Greving2011 ER - TY - JOUR AU - Ringborg, A. AU - Nieuwlaat, R. AU - Lindgren, P. AU - Jonsson, B. AU - Fidan, D. AU - Maggioni, A. P. AU - Lopez-Sendon, J. AU - Stepinska, J. AU - Cokkinos, D. V. AU - Crijns, H. J. PY - 2008 DA - 2008// TI - Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation JO - Europace. VL - 10 UR - https://doi.org/10.1093/europace/eun048 DO - 10.1093/europace/eun048 ID - Ringborg2008 ER - TY - JOUR AU - Soekhlal, R. R. AU - Burgers, L. T. AU - Redekop, W. K. AU - Tan, S. S. PY - 2013 DA - 2013// TI - Treatment costs of acute myocardial infarction in the Netherlands JO - Neth Heart J. VL - 21 UR - https://doi.org/10.1007/s12471-013-0386-y DO - 10.1007/s12471-013-0386-y ID - Soekhlal2013 ER - TY - JOUR AU - Mastrigt, G. A. AU - Heijmans, J. AU - Severens, J. L. AU - Fransen, E. J. AU - Roekaerts, P. AU - Voss, G. AU - Maessen, J. G. PY - 2006 DA - 2006// TI - Short-stay intensive care after coronary artery bypass surgery: randomized clinical trial on safety and cost-effectiveness JO - Crit Care Med. VL - 34 UR - https://doi.org/10.1097/01.CCM.0000191266.72652.FA DO - 10.1097/01.CCM.0000191266.72652.FA ID - Mastrigt2006 ER - TY - STD TI - Dutch guideline for economic evaluations in healthcare 2016. www.zorginstituutnederland.nl. Accessed on: 23-09-2016. UR - http://www.zorginstituutnederland.nl ID - ref40 ER - TY - JOUR AU - Attema, A. E. AU - Brouwer, W. B. F. AU - Claxton, K. PY - 2018 DA - 2018// TI - Discounting in economic evaluations JO - Pharmacoeconomics. VL - 36 UR - https://doi.org/10.1007/s40273-018-0672-z DO - 10.1007/s40273-018-0672-z ID - Attema2018 ER - TY - STD TI - Dutch National Health Care Institute. Costeffectiveness in practice. 2015. https://www.zorginstituutnederland.nl/publicaties/rapport/2015/06/26/kosteneffectiviteit-in-de-praktijk. UR - https://www.zorginstituutnederland.nl/publicaties/rapport/2015/06/26/kosteneffectiviteit-in-de-praktijk ID - ref42 ER - TY - JOUR AU - Wilkins, J. T. AU - Ning, H. AU - Berry, J. AU - Zhao, L. AU - Dyer, A. R. AU - Lloyd-Jones, D. M. PY - 2012 DA - 2012// TI - Lifetime risk and years lived free of total cardiovascular disease JO - Jama. VL - 308 UR - https://doi.org/10.1001/jama.2012.14312 DO - 10.1001/jama.2012.14312 ID - Wilkins2012 ER - TY - JOUR AU - Doll, R. AU - Peto, R. AU - Boreham, J. AU - Sutherland, I. PY - 2004 DA - 2004// TI - Mortality in relation to smoking: 50 years’ observations on male British doctors JO - BMJ. VL - 328 UR - https://doi.org/10.1136/bmj.38142.554479.AE DO - 10.1136/bmj.38142.554479.AE ID - Doll2004 ER - TY - STD TI - Dehmer SP, Maciosek MV, Flottemesch TJ, LaFrance AB and Whitlock EP. Aspirin for the primary prevention of cardiovascular disease and colorectal cancer: a decision analysis for the U.S. Preventive Services Task Force. Annals of internal medicine. 2016. ID - ref45 ER - TY - JOUR AU - Schievink, B. AU - Kropelin, T. AU - Mulder, S. AU - Parving, H. H. AU - Remuzzi, G. AU - Dwyer, J. AU - Vemer, P. AU - Zeeuw, D. AU - Lambers Heerspink, H. J. PY - 2016 DA - 2016// TI - Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes JO - Diabetes, obesity & metabolism. VL - 18 UR - https://doi.org/10.1111/dom.12583 DO - 10.1111/dom.12583 ID - Schievink2016 ER - TY - JOUR AU - Ferket, B. S. AU - Kempen, B. J. AU - Heeringa, J. AU - Spronk, S. AU - Fleischmann, K. E. AU - Nijhuis, R. L. AU - Hofman, A. AU - Steyerberg, E. W. AU - Hunink, M. G. PY - 2012 DA - 2012// TI - Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study JO - PLoS Med. VL - 9 UR - https://doi.org/10.1371/journal.pmed.1001361 DO - 10.1371/journal.pmed.1001361 ID - Ferket2012 ER -